Two Sigma Advisers’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.2K | Sell |
20,281
-1,300
| -6% | -$3.47K | ﹤0.01% | 2249 |
|
|
2025
Q1 | $173K | Sell |
21,581
-6
| -0% | -$48 | ﹤0.01% | 2170 |
|
|
2024
Q4 | $209K | Sell |
21,587
-513
| -2% | -$4.96K | ﹤0.01% | 2115 |
|
|
2024
Q3 | $411K | Sell |
22,100
-5,465
| -20% | -$102K | ﹤0.01% | 1782 |
|
|
2024
Q2 | $459K | Buy |
27,565
+14,591
| +112% | +$243K | ﹤0.01% | 1917 |
|
|
2024
Q1 | $225K | Buy |
12,974
+8,678
| +202% | +$151K | ﹤0.01% | 2176 |
|
|
2023
Q4 | $67.2K | Buy |
+4,296
| New | +$67.2K | ﹤0.01% | 2371 |
|
|
2022
Q4 | – | Sell |
-491
| Closed | -$89K | – | 2733 |
|
|
2022
Q3 | $89K | Sell |
491
-1,187
| -71% | -$215K | ﹤0.01% | 2322 |
|
|
2022
Q2 | $151K | Buy |
1,678
+430
| +34% | +$38.7K | ﹤0.01% | 2334 |
|
|
2022
Q1 | $194K | Buy |
1,248
+687
| +122% | +$107K | ﹤0.01% | 2390 |
|
|
2021
Q4 | $167K | Buy |
+561
| New | +$167K | ﹤0.01% | 2332 |
|